An advisory panel is to vote later this week on whether to recommend emergency authorization of boosters for the Moderna and Johnson & Johnson vaccines.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register. By continuing to use this site, you are consenting to our use of cookies.